Trials / Not Yet Recruiting
Not Yet RecruitingNCT06932861
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Xinxin Zhang · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
An Exploratory Study on the Use of mRNA Tumor Vaccines in the Treatment of Refractory Rhabdomyosarcoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | mRNA Tumor Vaccine Therapy | personalized mRNA vaccines |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Completion
- 2028-05-01
- First posted
- 2025-04-17
- Last updated
- 2025-04-22
Source: ClinicalTrials.gov record NCT06932861. Inclusion in this directory is not an endorsement.